According to diabetes management guidelines, first-line therapy with metformin monotherapy is recommended, and if HbA1C target levels are not achieved, dual therapy with metformin plus sulfonylureas or DPP-4 inhibitors will be used [16]. The gene discussed is DPP4; the disease is diabetes mellitus.